CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$56.00 +1.91 (+3.53%)
At close: Sep 29, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Net Margin (2016 - 2026)

Updated

CRISPR Therapeutics AG's Net Margin came in at -895.33% for Q2 2026, up 22484.60 percentage points from -23379.93% a year earlier and up 7536.15 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Net Margin (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, CRISPR Therapeutics AG reported Net Margin of -3368.72%, down 2139.29 percentage points year-over-year; for FY2025, it was -16569.77%, down 15588.23 percentage points from FY2024.

  • Net Margin carries a five-year change of +31951.09 percentage points (FY2020 to FY2025).
  • Going back by year, Net Margin was -981.54% in FY2024 (-940.16 pp), -41.38% in FY2023 (+54230.32 pp), -54271.70% in FY2022 (-54312.98 pp) and 41.28% in FY2021 (+48562.14 pp).
  • The Q2 2026 figure represents the highest quarterly Net Margin since Q4 2024.
  • Year-over-year, Net Margin increased in five of the last seven quarters, with an average year-over-year change of +3628.27 percentage points.
  • The fastest year-over-year change in Net Margin over five years came in Q4 2023 (a gain of 1842961.07 percentage points), and the weakest in Q4 2022 (a drop of 1841821.64 percentage points).
  • Business Quant data shows CRSP's Net Margin at -8431.48% (Q1 2026), -15117.25% (Q4 2025) and -11973.12% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 CRISPR Therapeutics AG 5.23 Bn 5.23 Bn - -895.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -895.33%
Mar 31, 2026 -8,431.48%
Dec 31, 2025 -15,117.25%
Sep 30, 2025 -11,973.12%
Jun 30, 2025 -23,379.93%
Mar 31, 2025 -15,722.08%
Dec 31, 2024 -104.54%
Sep 30, 2024 -14,276.08%
Jun 30, 2024 -24,450.29%
Mar 31, 2024 -23,133.13%
Dec 31, 2023 44.41%
Jun 30, 2023 -111.06%
Mar 31, 2023 -53.07%
Dec 31, 2022 -1,842,916.67%
Sep 30, 2022 -185,690.43%
Jun 30, 2022 -117,616.46%
Mar 31, 2022 -19,065.64%
Dec 31, 2021 -1,095.03%
Sep 30, 2021 -15,431.19%
Jun 30, 2021 84.29%
API Access

CRISPR Therapeutics AG Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY